How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests?
Kilbride, Madison K
How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests? [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 10 2019 - 2514-2517 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
1527-7755
10.1200/JCO.18.01418 doi
Adult
Breast Neoplasms--prevention & control
Direct-To-Consumer Screening and Testing--methods
Female
Health Personnel--psychology
Humans
Language
Patients--psychology
Prophylactic Mastectomy--methods
United States
United States Food and Drug Administration--standards
How Should Patients and Providers Interpret the US Food and Drug Administration's Regulatory Language for Direct-to-Consumer Genetic Tests? [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 10 2019 - 2514-2517 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
1527-7755
10.1200/JCO.18.01418 doi
Adult
Breast Neoplasms--prevention & control
Direct-To-Consumer Screening and Testing--methods
Female
Health Personnel--psychology
Humans
Language
Patients--psychology
Prophylactic Mastectomy--methods
United States
United States Food and Drug Administration--standards